Entwicklung und Charakterisierung von 4-1BB-spezifischen Agonisten: = Development and characterization of 4-1BB specific agonists
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis Book |
| Language: | German |
| Published: |
Würzburg
Oktober 2020
|
| Subjects: | |
| Online Access: | Volltext |
| Item Description: | erschienen 2021 |
| Physical Description: | XI, 94 Seiten Diagramme |
| DOI: | 10.25972/OPUS-23428 |
Staff View
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV047345527 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 210625s2020 gw |||| m||| 00||| ger d | ||
| 015 | |a 21,O06 |2 dnb | ||
| 035 | |a (OCoLC)1257814703 | ||
| 035 | |a (DE-599)BVBBV047345527 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |8 3\p |a ger | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-20 |a DE-384 |a DE-473 |a DE-703 |a DE-1051 |a DE-824 |a DE-29 |a DE-12 |a DE-91 |a DE-19 |a DE-1049 |a DE-92 |a DE-739 |a DE-898 |a DE-355 |a DE-706 |a DE-1102 |a DE-860 |a DE-2174 | ||
| 084 | |8 2\p |a 610 |2 23sdnb | ||
| 084 | |8 1\p |a 616.079 |2 23ksdnb | ||
| 100 | 1 | |a Austein, Kristof |d 19XX- |e Verfasser |0 (DE-588)1236042425 |4 aut | |
| 245 | 1 | 0 | |a Entwicklung und Charakterisierung von 4-1BB-spezifischen Agonisten |b = Development and characterization of 4-1BB specific agonists |c vorgelegt von Kristof Austein aus Bremen |
| 246 | 1 | 1 | |a Development and characterization of 4-1BB specific agonists |
| 264 | 1 | |a Würzburg |c Oktober 2020 | |
| 300 | |a XI, 94 Seiten |b Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a erschienen 2021 | ||
| 502 | |b Dissertation |c Julius-Maximilians-Universität Würzburg |d 2021 | ||
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |5 DE-101 |2 pdager | |
| 650 | 0 | 7 | |8 4\p |a Antikörper |0 (DE-588)4002290-0 |2 gnd |
| 650 | 0 | 7 | |8 5\p |a Proteine |0 (DE-588)4076388-2 |2 gnd |
| 650 | 0 | 7 | |8 6\p |a Monoklonaler Antikörper |0 (DE-588)4040094-3 |2 gnd |
| 650 | 0 | 7 | |8 7\p |a Monoklonaler bispezifischer Antikörper |0 (DE-588)4326199-1 |2 gnd |
| 650 | 0 | 7 | |8 8\p |a Zelle |0 (DE-588)4067537-3 |2 gnd |
| 653 | |a TNRSF | ||
| 653 | |a antibody | ||
| 653 | |a 4-1BB Agonist | ||
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |o urn:nbn:de:bvb:20-opus-234285 |o doi:10.25972/OPUS-23428 |
| 856 | 4 | 1 | |u https://doi.org/10.25972/OPUS-23428 |x Resolving-System |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032747828 | ||
| 883 | 0 | |8 1\p |a aepkn |c 0,98337 |d 20210504 |q DE-101 |u https://d-nb.info/provenance/plan#aepkn | |
| 883 | 0 | |8 2\p |a aepsg |c 0,99990 |d 20210504 |q DE-101 |u https://d-nb.info/provenance/plan#aepsg | |
| 883 | 1 | |8 3\p |a npi |d 20210503 |q DE-101 |u https://d-nb.info/provenance/plan#npi | |
| 883 | 0 | |8 4\p |a aepgnd |c 0,19291 |d 20210504 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
| 883 | 0 | |8 5\p |a aepgnd |c 0,07953 |d 20210504 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
| 883 | 0 | |8 6\p |a aepgnd |c 0,04721 |d 20210504 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
| 883 | 0 | |8 7\p |a aepgnd |c 0,03125 |d 20210504 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
| 883 | 0 | |8 8\p |a aepgnd |c 0,03047 |d 20210504 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
Record in the Search Index
| _version_ | 1804182565221826560 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Austein, Kristof 19XX- |
| author_GND | (DE-588)1236042425 |
| author_facet | Austein, Kristof 19XX- |
| author_role | aut |
| author_sort | Austein, Kristof 19XX- |
| author_variant | k a ka |
| building | Verbundindex |
| bvnumber | BV047345527 |
| collection | ebook |
| ctrlnum | (OCoLC)1257814703 (DE-599)BVBBV047345527 |
| doi_str_mv | 10.25972/OPUS-23428 |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02782nam a2200577zc 4500</leader><controlfield tag="001">BV047345527</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">210625s2020 gw |||| m||| 00||| ger d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">21,O06</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1257814703</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047345527</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">ger</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-20</subfield><subfield code="a">DE-384</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-1051</subfield><subfield code="a">DE-824</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-1049</subfield><subfield code="a">DE-92</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-898</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-706</subfield><subfield code="a">DE-1102</subfield><subfield code="a">DE-860</subfield><subfield code="a">DE-2174</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">2\p</subfield><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">616.079</subfield><subfield code="2">23ksdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Austein, Kristof</subfield><subfield code="d">19XX-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1236042425</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Entwicklung und Charakterisierung von 4-1BB-spezifischen Agonisten</subfield><subfield code="b">= Development and characterization of 4-1BB specific agonists</subfield><subfield code="c">vorgelegt von Kristof Austein aus Bremen</subfield></datafield><datafield tag="246" ind1="1" ind2="1"><subfield code="a">Development and characterization of 4-1BB specific agonists</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Würzburg</subfield><subfield code="c">Oktober 2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 94 Seiten</subfield><subfield code="b">Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">erschienen 2021</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Julius-Maximilians-Universität Würzburg</subfield><subfield code="d">2021</subfield></datafield><datafield tag="583" ind1="1" ind2=" "><subfield code="a">Archivierung/Langzeitarchivierung gewährleistet</subfield><subfield code="5">DE-101</subfield><subfield code="2">pdager</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">4\p</subfield><subfield code="a">Antikörper</subfield><subfield code="0">(DE-588)4002290-0</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">5\p</subfield><subfield code="a">Proteine</subfield><subfield code="0">(DE-588)4076388-2</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">6\p</subfield><subfield code="a">Monoklonaler Antikörper</subfield><subfield code="0">(DE-588)4040094-3</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">7\p</subfield><subfield code="a">Monoklonaler bispezifischer Antikörper</subfield><subfield code="0">(DE-588)4326199-1</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">8\p</subfield><subfield code="a">Zelle</subfield><subfield code="0">(DE-588)4067537-3</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TNRSF</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibody</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">4-1BB Agonist</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="o">urn:nbn:de:bvb:20-opus-234285</subfield><subfield code="o">doi:10.25972/OPUS-23428</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">https://doi.org/10.25972/OPUS-23428</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032747828</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">aepkn</subfield><subfield code="c">0,98337</subfield><subfield code="d">20210504</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepkn</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">aepsg</subfield><subfield code="c">0,99990</subfield><subfield code="d">20210504</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepsg</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">npi</subfield><subfield code="d">20210503</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#npi</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,19291</subfield><subfield code="d">20210504</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">5\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,07953</subfield><subfield code="d">20210504</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">6\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,04721</subfield><subfield code="d">20210504</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">7\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,03125</subfield><subfield code="d">20210504</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">8\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,03047</subfield><subfield code="d">20210504</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV047345527 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T17:35:53Z |
| indexdate | 2024-07-10T09:09:34Z |
| institution | BVB |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032747828 |
| oclc_num | 1257814703 |
| open_access_boolean | 1 |
| owner | DE-20 DE-384 DE-473 DE-BY-UBG DE-703 DE-1051 DE-824 DE-29 DE-12 DE-91 DE-BY-TUM DE-19 DE-BY-UBM DE-1049 DE-92 DE-739 DE-898 DE-BY-UBR DE-355 DE-BY-UBR DE-706 DE-1102 DE-860 DE-2174 |
| owner_facet | DE-20 DE-384 DE-473 DE-BY-UBG DE-703 DE-1051 DE-824 DE-29 DE-12 DE-91 DE-BY-TUM DE-19 DE-BY-UBM DE-1049 DE-92 DE-739 DE-898 DE-BY-UBR DE-355 DE-BY-UBR DE-706 DE-1102 DE-860 DE-2174 |
| physical | XI, 94 Seiten Diagramme |
| psigel | ebook |
| publishDate | 2020 |
| publishDateSearch | 2020 |
| publishDateSort | 2020 |
| record_format | marc |
| spelling | Austein, Kristof 19XX- Verfasser (DE-588)1236042425 aut Entwicklung und Charakterisierung von 4-1BB-spezifischen Agonisten = Development and characterization of 4-1BB specific agonists vorgelegt von Kristof Austein aus Bremen Development and characterization of 4-1BB specific agonists Würzburg Oktober 2020 XI, 94 Seiten Diagramme txt rdacontent n rdamedia nc rdacarrier erschienen 2021 Dissertation Julius-Maximilians-Universität Würzburg 2021 Archivierung/Langzeitarchivierung gewährleistet DE-101 pdager 4\p Antikörper (DE-588)4002290-0 gnd 5\p Proteine (DE-588)4076388-2 gnd 6\p Monoklonaler Antikörper (DE-588)4040094-3 gnd 7\p Monoklonaler bispezifischer Antikörper (DE-588)4326199-1 gnd 8\p Zelle (DE-588)4067537-3 gnd TNRSF antibody 4-1BB Agonist (DE-588)4113937-9 Hochschulschrift gnd-content Erscheint auch als Online-Ausgabe urn:nbn:de:bvb:20-opus-234285 doi:10.25972/OPUS-23428 https://doi.org/10.25972/OPUS-23428 Resolving-System kostenfrei Volltext 1\p aepkn 0,98337 20210504 DE-101 https://d-nb.info/provenance/plan#aepkn 2\p aepsg 0,99990 20210504 DE-101 https://d-nb.info/provenance/plan#aepsg 3\p npi 20210503 DE-101 https://d-nb.info/provenance/plan#npi 4\p aepgnd 0,19291 20210504 DE-101 https://d-nb.info/provenance/plan#aepgnd 5\p aepgnd 0,07953 20210504 DE-101 https://d-nb.info/provenance/plan#aepgnd 6\p aepgnd 0,04721 20210504 DE-101 https://d-nb.info/provenance/plan#aepgnd 7\p aepgnd 0,03125 20210504 DE-101 https://d-nb.info/provenance/plan#aepgnd 8\p aepgnd 0,03047 20210504 DE-101 https://d-nb.info/provenance/plan#aepgnd |
| spellingShingle | Austein, Kristof 19XX- Entwicklung und Charakterisierung von 4-1BB-spezifischen Agonisten = Development and characterization of 4-1BB specific agonists 4\p Antikörper (DE-588)4002290-0 gnd 5\p Proteine (DE-588)4076388-2 gnd 6\p Monoklonaler Antikörper (DE-588)4040094-3 gnd 7\p Monoklonaler bispezifischer Antikörper (DE-588)4326199-1 gnd 8\p Zelle (DE-588)4067537-3 gnd |
| subject_GND | (DE-588)4002290-0 (DE-588)4076388-2 (DE-588)4040094-3 (DE-588)4326199-1 (DE-588)4067537-3 (DE-588)4113937-9 |
| title | Entwicklung und Charakterisierung von 4-1BB-spezifischen Agonisten = Development and characterization of 4-1BB specific agonists |
| title_alt | Development and characterization of 4-1BB specific agonists |
| title_auth | Entwicklung und Charakterisierung von 4-1BB-spezifischen Agonisten = Development and characterization of 4-1BB specific agonists |
| title_exact_search | Entwicklung und Charakterisierung von 4-1BB-spezifischen Agonisten = Development and characterization of 4-1BB specific agonists |
| title_exact_search_txtP | Entwicklung und Charakterisierung von 4-1BB-spezifischen Agonisten = Development and characterization of 4-1BB specific agonists |
| title_full | Entwicklung und Charakterisierung von 4-1BB-spezifischen Agonisten = Development and characterization of 4-1BB specific agonists vorgelegt von Kristof Austein aus Bremen |
| title_fullStr | Entwicklung und Charakterisierung von 4-1BB-spezifischen Agonisten = Development and characterization of 4-1BB specific agonists vorgelegt von Kristof Austein aus Bremen |
| title_full_unstemmed | Entwicklung und Charakterisierung von 4-1BB-spezifischen Agonisten = Development and characterization of 4-1BB specific agonists vorgelegt von Kristof Austein aus Bremen |
| title_short | Entwicklung und Charakterisierung von 4-1BB-spezifischen Agonisten |
| title_sort | entwicklung und charakterisierung von 4 1bb spezifischen agonisten development and characterization of 4 1bb specific agonists |
| title_sub | = Development and characterization of 4-1BB specific agonists |
| topic | 4\p Antikörper (DE-588)4002290-0 gnd 5\p Proteine (DE-588)4076388-2 gnd 6\p Monoklonaler Antikörper (DE-588)4040094-3 gnd 7\p Monoklonaler bispezifischer Antikörper (DE-588)4326199-1 gnd 8\p Zelle (DE-588)4067537-3 gnd |
| topic_facet | Antikörper Proteine Monoklonaler Antikörper Monoklonaler bispezifischer Antikörper Zelle Hochschulschrift |
| url | https://doi.org/10.25972/OPUS-23428 |
| work_keys_str_mv | AT austeinkristof entwicklungundcharakterisierungvon41bbspezifischenagonistendevelopmentandcharacterizationof41bbspecificagonists AT austeinkristof developmentandcharacterizationof41bbspecificagonists |